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Abstract
Glucocorticosteroids are used as a main treatment to reduce
airway inflammation in people with asthma who suffer from
neutrophilic airway inflammation, a condition frequently associ-
ated with Haemophilus influenzae colonization. Here we show that
glucocorticosteroids have a direct influence on the behavior of
H. influenzae that may account for associated difficulties with
therapy. Using a mouse model of infection, we show that cortico-
steroid treatment promotes H. influenzae persistence. Transcrip-
tomic analysis of bacteria either isolated from infected mouse
airway or grown in laboratory medium identified a number of
genes encoding regulatory factors whose expression responded to
the presence of glucocorticosteroids. Importantly, a number of
these corticosteroid-responsive genes also showed elevated
expression in H. influenzae within sputum from asthma patients
undergoing steroid treatment. Addition of corticosteroid to
H. influenzae led to alteration in biofilm formation and enhanced
resistance to azithromycin, and promoted azithromycin resistance
in an animal model of respiratory infection. Taken together, these
data strongly suggest that H. influenzae can respond directly to
corticosteroid treatment in the airway potentially influencing
biofilm formation, persistence and the efficacy of antibiotic
treatment.
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Introduction
Asthma is a chronic inflammatory condition of the airways,
frequently distinguished by abnormal immune responses to environ-
mental antigens and microbes, which leads to recurrent episodes of
cough, wheezing and breathlessness (Wenzel, 2006, 2012). An
estimated 300 million people worldwide suffer from asthma. Up to
30% of these patients suffer from neutrophilic asthma, which is
characterized by substantial increases in airway neutrophils.
Chronic colonization by bacteria is evident in the airways of patients
with neutrophilic asthma, with Haemophilus influenzae being the
species most frequently isolated.
Inhaled glucocorticosteroids, through their potent anti-
inflammatory action, are the foundation of asthma therapy (Ito
et al, 2006). However, in a very high proportion of cases, neutro-
philic asthmatics respond poorly to glucocorticosteroid treatment
(Essilfie et al, 2011, 2012). Chronic bacterial infection has been
associated with steroid-resistant neutrophilic asthma, although the
mechanisms producing treatment resistance in such infections are
poorly understood (Beigelman et al, 2014). The occurrence of
Haemophilus spp., Streptococcus spp. or Moraxella catarrhalis in the
neutrophilic asthmatic airway has been positively correlated with
sputum neutrophilia and lower FEV1. The presence of H. influenzae
in particular has been associated with the activation of airway
inflammation pathways in those asthmatics with relative steroid
resistance (Green et al, 2014). H. influenzae infection has been
shown to contribute in part to allergic airways disease through
alterations in IL-17 (Simpson et al, 2006; Berry et al, 2007). Further-
more, a strong relationship between chronic H. influenzae infection
and the development of steroid-resistant neutrophilic asthma has
been suggested using murine models of ovalbumin (OVA)-induced
allergic airway disease (Essilfie et al, 2011, 2012). In this model, the
combination of infection and allergic airways disease promotes
bacterial persistence leading to the development of a phenotype
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similar to steroid-resistant neutrophilic asthma. These findings indi-
cate that targeting bacterial infection in steroid-resistant asthma
may have a therapeutic benefit.
One aspect of the pathogenesis and therapy of neutrophilic
asthma that has not received consideration is the potential direct
influence of glucocorticosteroids on the behavior of H. influenzae.
There are no reports of a direct antibacterial action of glucocortico-
steroids; nevertheless, an impact on bacterial functions that promote
persistence and tolerance to antibiotics might impinge on the effi-
cacy of therapy. In this context, it is noteworthy that the severity of
asthma appears to be increased in patients with bacterial infections
who have received prolonged therapy with glucocorticosteroids.
Here we have examined the impact of glucocorticosteroid treat-
ment on H. influenzae during respiratory infection and neutrophilic
asthma, as well as investigating impacts of this therapeutic in vitro
on H. influenzae biology. Using a mouse model of acute infection,
we show that the presence of glucocorticosteroids promotes
H. influenzae persistence without influencing the host inflammatory
response. Comparative transcriptional analysis of H. influenzae
grown under standard laboratory conditions in the absence and
presence of beclomethasone revealed that this glucocorticosteroid
induces altered expression of genes implicated in biofilm formation
and host colonization. Furthermore, the majority of these genes
showed similar alterations in expression when transcriptomes of
bacteria grown in medium without glucocorticosteroid were
compared with those of bacteria isolated from the airway of infected
mice. Importantly, many of the H. influenzae genes with expression
that was responsive to corticosteroid in vitro also had altered
expression in bacteria within sputum samples from asthma patients
undertaking inhaled steroid treatment. In parallel, we examined the
influence of glucocorticosteroids on H. influenzae behavior by
addressing the effects on biofilm formation and resistance to
azithromycin, a frontline drug prescribed to asthma patients. Addi-
tion of glucocorticosteroids changed the architecture and increased
the tolerance to azithromycin of H. influenzae biofilms developed in
flow cells. Finally, we developed a mutant screen that allowed the
identification of a potential role for the RpoE-MclA sigma factor–
anti-sigma factor system (HI0628–HI0629) as a mediator of this
glucocorticosteroid response. Taken together, these findings indicate
that H. influenzae can respond directly to glucocorticosteroid treat-
ment in the lung where it may influence biofilm formation, persis-
tence and the efficacy of antibiotic therapy.
Results
Glucocorticosteroids promote H. influenzae persistence in a
mouse model
Mouse models of H. influenzae have been rarely reported since it is
difficult for this bacterium to infect mice (Vallee et al, 1992; Wu
et al, 1997). Here, we pursued a new mouse model of lung infection
in order to determine whether glucocorticosteroids have the ability
to modulate H. influenzae infection. We used 4-week-old C57BL/6
mice to assess the effects of supplementation of H. influenzae with
beclomethasone, a model glucocorticosteroid used widely in the
clinic (van den Berge et al, 2011), on the bacterial load in the lung.
Generally, young immature mice are more susceptible to bacterial
infection than fully grown mice. In addition, the mice were pre-
treated intraperitoneally with cyclophosphamide to induce granulo-
cytopenia. When cyclophosphamide-pretreated mice were
intranasally inoculated with 1 × 109 CFU of H. influenzae, the
bacteria resided in the lungs of the mice at more than 105 CFU for
up to 3–4 days post-inoculation.
Next, the cyclophosphamide-treated C57BL/6 mice were infected
with H. influenzae and treated by inhaling PBS with or without
50 lM beclomethasone, a clinically relevant dose based on the
weight of the mice used (Daley-Yates et al, 2001). The lung and
spleen bacterial load was determined at 1, 3, 5 or 7 days post-
infection. C57BL/6 mice infected with H. influenzae with PBS cleared
almost all bacteria from the lungs within 5 days (Fig 1A). However,
with the addition of beclomethasone, bacteria were still present in
substantial numbers at 7 days (Fig 1A), with ~1,000-fold more
bacteria present in the beclomethasone-treated mice versus control.
Similar patterns were seen in the bacterial loads in the spleen,
where after 7 days the numbers of bacteria in beclomethasone-
treated mice were significantly higher (~1.5 log higher) than in
untreated mice (Fig 1B). To extend this study, we also examined the
influence of mometasone and prednisolone, two other glucocorticos-
teroids in clinical use, on H. influenzae survival in the cyclophos-
phamide-mouse model. Treatment with prednisolone (50 lM) gave
a similar increased persistence phenotype as was observed for
beclomethasone treatment (Supplementary Fig S1). Mometasone
(50 lM) also appeared to promote H. influenzae persistence,
although its influence was considerably less than the other two
steroids tested.
The effects of beclomethasone on H. influenzae persistence
were also examined in C57BL/6 mice that did not receive the
cyclophosphamide treatment. The same trend was observed where
beclomethasone treatment enhanced H. influenzae persistence in
the airway, although in this case, no dissemination to the spleen
was seen (Supplementary Fig S2). Taken together, these data indi-
cate that treatment with beclomethasone enhanced H. influenzae
persistence in the airway and systemically in this model of infection.
Numerous previous studies have demonstrated H. influenzae
infection of the murine airway induces the recruitment of leukocytes
and other inflammation markers, which mirrors in part what is seen
in a clinical setting (Hansen et al, 1988; Essilfie et al, 2011, 2012).
In the current study, the inflammatory response of challenged mice
was examined in terms of total leukocyte recruitment in the airways
(see Materials and Methods). In the first set of experiments, mice
were pre-treated with cyclophosphamide. At 3 days post-infection,
the cell numbers that influx into the airways (including neutrophils,
lymphocyte and eosinophils) were similar in beclomethasone-
treated mice and mice that were treated with PBS only (Fig 1C). By
7 days post-infection, however, neutrophil numbers in the mice
treated with beclomethasone remained at the level seen at 3 days
and were significantly higher than those seen in PBS alone (Fig 1D).
In contrast, overall lymphocyte numbers were similar in mice
treated with beclomethasone compared with mice treated with PBS
alone (Fig 1D). The effects of beclomethasone on the inflammatory
response induced by H. influenzae in C57BL/6 mice that did not
receive the cyclophosphamide treatment were also examined. In this
case, more neutrophils were recruited on day 3 as with the cyclo-
phosphamide-treated mice (Supplementary Fig S2), but this eleva-
tion returned to normal levels by day 4.
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The observed continued recruitment of neutrophils at day 7 in
the cyclophosphamide-mouse model of H. influenzae infection was
unexpected. However, this observation is not unprecedented in the
clinical setting; examination of neutrophilic asthma patients showed
neutrophil numbers increase in those patients undergoing inhaled
corticosteroid treatment (see Simpson et al, 2006). Overall, our
results suggest that the presence of beclomethasone increases the
capacity of H. influenzae to persist in mice but these findings do not
establish whether this is a direct effect of the glucocorticosteroid on
the bacteria or whether this is an indirect effect, mediated through
an influence on the host, including recruitment of immune cells.
Glucocorticosteroids induce specific changes in H. influenzae
gene expression in culture
As an approach to understanding the possible direct influence of
glucocorticosteroids on H. influenzae, we examined the impact of
beclomethasone on gene expression of bacteria using high-throughput
cDNA sequencing techniques. For these experiments, bacteria were
grown in complex sBHI medium, which is brain–heart infusion
medium supplemented with hemin and NAD (see Materials and
Methods). RNA was derived from bacteria grown in the presence
and absence of beclomethasone (50 lM) and, following rRNA deple-
tion, the remaining RNA was fragmented, reverse-transcribed into
cDNA and sequenced using the Illumina platform. Between 20 and
30 million reads were derived from each sample, which were
aligned to non-rRNA sequences in the H. influenzae genome,
comprising the 1,788 annotated ORFs (Supplementary Table S1).
The correlation of technical replicates was very high, suggesting that
variations introduced during library construction and sequencing do
not significantly contribute to differences in gene expression
between samples. A total of 61 genes were significantly differentially
expressed by at least threefold (Padj < 1 × 10
5) during growth of
H. influenzae in sBHI in the presence or absence of beclomethasone
(see Materials and Methods). Of the 61 genes regulated by beclo-
methasone, 29 genes were up-regulated and 32 genes were down-
regulated (Fig 2A and B and Supplementary Table S2).
Those genes whose expression was increased by beclomethasone
treatment included those with protein products involved in adaptive
responses such as iron uptake (HI0994), biofilm formation
(HI1344), stress response (HI0628) and antimicrobial resistance
(HI1275) as well as the yfe operon (HI0359–HI0362), which encodes
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Figure 1. Administration of corticosteroids promotes the persistence of H. influenzae in mice.
A–D C57BL/6 mice were infected with H. influenzae in PBS with or without supplementation with beclomethasone. Animals were killed at 1, 3, 5 and 7 days after
infection, and 10-fold serial dilutions of the lung homogenates (A) and spleen homogenates (B) were plated to determine the bacterial load. Airway inflammation
represented by total and differential cell counts in bronchoalveolar lavage fluid (BALF). The number of total leukocytes and in particular of neutrophils, monocytes
and lymphocytes recruited in the airways was analyzed in BALF after day 3 (C) and day 7 (D) of infection.
Data information: Values represent the mean  standard deviation (SD). The data are pooled from three independent experiments. Statistical significance by two-tailed
Student’s t-test is indicated: *P < 0.05, **P < 0.01.
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an ABC transporter putatively involved in metal ion uptake and
previously implicated in H. influenzae virulence regulation, adher-
ence to host cells and host immune evasion (Whitby et al, 2006;
Jalalvand et al, 2013; Su et al, 2013).
The effect of beclomethasone on the level of transcript was
validated by quantitative reverse-transcription polymerase chain
reaction (qRT–PCR). The genes selected for these analyses repre-
sented those from diverse functional classes with some previously
implicated in virulence and biofilm regulation in H. influenzae with
a fold change of three or higher (Fig 2C). Importantly, this subset of
those genes that showed a response to beclomethasone showed a
similar alteration in expression when H. influenzae was cultured in
the presence of prednisolone, another glucocorticosteroid taken by
asthmatics (Supplementary Figs S3 and S4). In contrast, many of
these genes showed no alteration in expression in response to dehy-
droepiandrosterone, an unrelated steroid that is found abundantly
in human tissue (Supplementary Fig S3).
Genes showing specific changes in expression during
H. influenzae infection include a subset that is influenced by
glucocorticosteroids in culture
The effects of glucocorticosteroids on gene expression of H. influenzae
in culture raised the issue of whether similar alterations in gene
expression occur in the mouse model treated with glucocorti-
costeroids. As with other opportunistic pathogens, H. influenzae
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Figure 2. H. influenzae genes differentially regulated during growth in complex media and during lung infection in the presence of corticosteroids.
A Venn diagram showing the overlap of H. influenzae genes whose expression is up-regulated or down-regulated by the presence of corticosteroids in sBHI medium
(in vitro) or in the mouse model of infection (in vivo). Genes that are divergently regulated in these conditions are not depicted in this Venn diagram but can be
found in the complete RNA-Seq dataset detailed in Supplementary Table S2.
B COG map detailing significantly enriched or scarce functional categories expressed in vitro and in vivo during the presence of corticosteroids.
C, D Comparison of relative fold changes between RNA-seq and qRT–PCR results in vitro (C) and in vivo (D) in the presence of corticosteroids. All qRT–PCR results were
normalized using the Cts obtained for the 16S rRNA amplifications run in the same plate. The relative levels of gene transcripts are determined from standard
curves. Values given are the mean and standard deviation of triplicate measurements (three biological and three technical replicates).
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modulates its gene expression upon colonization of its mammalian
host. To gain understanding of this adaptation of H. influenzae to the
host environment (in the presence of beclomethasone treatment), we
systematically cataloged the transcriptomes of bacteria grown in vivo,
using high-throughput cDNA sequencing techniques. RNA was
derived from organisms isolated directly from the lung homogenates
of infected mice and, following rRNA depletion, the remaining RNA
was fragmented, reverse-transcribed into cDNA and sequenced. Illu-
mina-based RNA-seq was used for the characterization of bacteria
within the lung tissue, which reach densities of 105 CFU/ml. We
chose to profile the infection 3 days post-inoculation because this
represents the midpoint of the trajectory of the infection.
A total of 35–40 million reads were derived from murine samples
and were aligned to non-rRNA sequences in the H. influenzae
genome (Supplementary Table S1). To identify genes that are differ-
entially expressed during murine infection and in sBHI medium with
or without glucocorticosteroid, we compared the RNA-seq data for
these conditions using DESeq, a differential expression analysis
package for RNA-seq data that presumes that abundance of reads
can be modeled by a negative binomial distribution (An et al,
2013). These analyses revealed that expression of 129 (7.2%) of the
1,788 annotated H. influenzae ORFs was significantly altered (> 3-
fold, Padj < 1 × 10
5) in the mouse model of infection by compari-
son with bacteria grown in culture without glucocorticosteroids;
expression of 58 genes (3.2%) was up-regulated, whereas expres-
sion of 71 genes (4.0%) was down-regulated (Fig 2A and B and
Supplementary Table S2).
Comparison of these alterations in the transcriptome with those
induced by the presence of beclomethasone in culture revealed a
significant overlap (Fig 2A and Supplementary Table S2). Neverthe-
less, a large number of genes (n = 82) whose expression is altered
in bacteria in the host are not regulated by glucocorticosteroids in
culture, consistent with the contention that these are responses of
H. influenzae to other aspects of the host environment. While the
majority of these differentially expressed genes were annotated as
hypothetical proteins, several have recently been shown to encode
factors required by H. influenzae for growth and/or colonization of
the host. These included HI0174 (mnmA), HI0274 (gltX), HI0479
(atpD), HI0629 (mclA), HI1547 (aroG) and HI1548 (lolE) (Gawronski
et al, 2009). Additional regulated genes encoded factors that have
been previously reported to contribute to H. influenzae virulence:
HI1544 which encodes a NAD(P)H oxidoreductase and HI1707
which encodes the sensor kinase, FirS (Steele et al, 2012).
To assess the reliability of RNA-seq data in determining the rela-
tive abundances of individual transcripts in the presence of beclo-
methasone, we used the same total RNA samples determined by
qRT–PCR: the mRNA levels of five up-regulated genes (HI0075,
HI0095, HI0628, HI1275 and HI1677) and four down-regulated genes
(HI0127, HI0811, HI1177 and HI1431) (Fig 2D). The ratios of the
transcripts from samples determined by RNA-seq to those obtained
by qRT–PCR were in concordance.
Transcript levels of glucocorticosteroid-responsive H. influenzae
genes in sputum from asthma patients
The above findings suggest that glucocorticosteroids may influence
the expression of specific H. influenzae genes in asthma patients.
In order to test this hypothesis, the transcript level of three
corticosteroid-responsive genes (HI0359, HI0628 and HI0994) was
established by qRT–PCR on sputum samples collected from twenty-
four asthma patients. A comparison of the demographics and
asthma characteristics of these patients are shown in Table 1.
There were no significant differences in gender, smoking history
(defined as % current and past smoker), obesity (defined as BMI
≥ 30 kg/m2), nasal disease, atopy and serum IgE. All patients were
taking standard inhaled glucocorticosteroid therapy using beclo-
methasone or mometasone routinely.
Inhaled beclomethasone is prescribed much more frequently (in
90% of cases) than mometasone, probably because it is effective
but of lower cost than mometasone (Friedman et al, 2010).
However, mometasone only needs to be administered once every
24 h, whereas beclomethasone is administered two or three times in
the same period. The clinical choice between beclomethasone and
mometasone is informed by cost, administration frequency as well
as past experience (Friedman et al, 2010).
Patients had a significant load of pathogenic bacteria in their
sputum as detected by culture methods. The bacteria detected
included H. influenzae, Pseudomonas aeruginosa, Staphylococcus
aureus, methicillin-resistant S. aureus (MRSA), Streptococcus
pneumoniae, Moraxella catarrhalis, Achromobacter xylosoxidans,
Klebsiella oxytoca and Stenotrophomonas maltophilia (Table 1).
H. influenzae was identified in 20 of the 24 sputum samples with
P. aeruginosa and S. aureus being even more commonly found. All
patients had more than one bacterial species cultured.
Total RNA was isolated from the 24 sputum samples obtained
from these asthma patients. Contaminating DNA was degraded,
total RNA was quantified, and equal amounts were subjected to
qRT–PCR. Overall, 20 of the 24 sputum samples from patients tested
positive for the expression of the selected corticosteroid-responsive
genes HI0359, HI0628 and HI0994. There was a direct correlation
between the presence of a qRT–PCR amplicon and the presence of
H. influenzae in sputum as revealed by culture but no correlation
with the presence of any other pathogenic bacteria. Notably, the
transcript level of these target genes was increased in patients who
were currently using beclomethasone compared to those who were
using mometasone (Table 1).
Clinical isolates of H. influenzae retain the ability to respond to
glucocorticosteroid
Although an elevated level of expression of corticoid-responsive
genes in H. influenzae strains in sputum from asthma patients is
consistent with a direct response to beclomethasone, the findings
do not exclude the possibility that clinical isolates have intrinsi-
cally higher levels of expression of these genes. To address this
issue, the ability of a panel of seven H. influenzae clinical isolates
to respond to glucocorticosteroids was assessed by measurement
of the expression of yfe operon (HI0359–HI0362) and HI0628 and
HI0994 by qRT–PCR. Addition of beclomethasone or prednisone to
the H. influenzae isolates led to the up-regulation of yfe operon
(HI0359–HI0362) and HI0628 and HI0994 in all strains, although to
varying degrees (Supplementary Table S3). However, the level of
alteration in expression in response to mometasone was consider-
ably reduced (Supplementary Table S3). Taken together, the find-
ings indicate that clinical isolates of H. influenzae retain the
ability to respond to beclomethasone.
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Identities of genes that mediate the response of H. influenzae to
glucocorticosteroids
We next sought to understand the mechanism by which beclo-
methasone impacts bacterial gene expression. As outlined above,
the addition of beclomethasone to H. influenzae cultures led to
increased expression of HI1677, which encodes an iron–sulfur
cluster repair protein (Fig 2D). This observation formed the basis
of a screen for genes involved in the beclomethasone response. A
reporter strain was constructed in which the luxCDABE genes were
put under control of the HI1677 promoter in the wild-type back-
ground (see Materials and Methods). This HI1677::lux reporter
strain was subjected to insertional mutagenesis using a kanamycin
resistance (KanR) cassette as described in the Materials and
Methods. A panel of approximately 4,000 mutants was screened for
altered bioluminescence in the presence of beclomethasone
(50 lM). Initially, 34 mutants that demonstrated altered expression
of the reporter fusion were isolated, and following a rescreening to
reduce false negatives, 19 candidates with altered response were
identified.
The sites of KanR cassette insertion for the non-responsive
mutants were mapped to the genome of H. influenzae by polymerase
chain reaction (PCR) and sequencing of amplicons (see Materials
and Methods). Southern blot analysis confirmed that only a
single copy of the cassette was inserted into the chromosome
in these non-responsive mutants. Insertion sites, which were all
different, were mapped to seven genetic loci with three genes found
more than once. None of the mutants showed impaired growth in
complex or minimal media, suggesting that the altered response to
corticosteroid could not be attributed to differences in growth
(Table 2).
Mutations were found in several genes encoding proteins
involved in stress response (such as HI0999 and HI1275), in genes
encoding hypothetical protein (HI1501) and in genes encoding
regulatory proteins including RpoE (HI0628). Other insertions
were found in genes that have been implicated in adaptation of
H. influenzae to infection of the murine lung (HI0334, HI0910 and
HI1605). RpoE (also known as rE) belongs to the extracytoplasmic
function (ECF) family of sigma factors (Craig et al, 2001, 2002).
These ECF sigma factors, often functioning together with a
Table 1. Summary of bacteria identified by culturing and the detection of bacterial gene transcription in the sputum from asthma patients.
Sample no. Age (y) and sex FEV1%
Inhaled steroid
treatmenta Detected bacterial strainsb
mRNA levelc
HI0359 HI0628 HI0994
S1 27 (M) 26 Bec Hi, Sp 24.9 (0.4) 4.4 (0.9) 7.1 (0.2)
S2 26 (F) 32 Bec Hi, Pa, Sa, MRSA, Ko, Sm 18.9 (0.4) 4.3 (0.6) 6.9 (0.6)
S3 26 (F) 29 Bec Hi, Pa, Sa, Ko, Sm 12.8 (0.1) 4.4 (0.2) 6.7 (0.3)
S5 24 (M) 33 Bec Hi, Sm, Mc 9.3 (0.9) 4.6 (0.8) 6.4 (0.2)
S8 22 (F) 23 Bec Hi, Pa, Sa, Ko, Sm 8.6 (0.2) 7.8 (0.2) 5.2 (0.2)
S9 26 (M) 24 Bec Hi, Pa, Sa, Ko, Sm 8.5 (0.1) 4.7 (0.8) 5.1 (0.1)
S10 25 (M) 33 Bec Hi, Pa, Sm, Mc 8.2 (0.3) 5.1 (0.4) 5.0 (0.7)
S12 26 (F) 31 Bec Hi, Pa, Sa, Ko, Sm 7.2 (0.3) 4.2 (0.6) 4.7 (0.4)
S13 26 (F) 30 Bec Hi, Pa, Sa, MRSA, Ko, Sm 6.3 (0.1) 4.0 (0.6) 4.2 (0.2)
S14 26 (F) 27 Bec Hi, Pa, Sa, Ko, Sm, Sp 6.2 (0.3) 3.0 (0.7) 4.1 (0.5)
S15 25 (F) 26 Bec Hi, Ko, Sm 6.0 (0.2) 3.3 (0.4) 3.9 (0.8)
S16 23 (M) 29 Bec Hi, Pa, Sa, Ko, Sm 5.2 (0.3) 2.9 (0.7) 3.5 (0.6)
S18 25 (M) 32 Bec Hi, Pa, Sa, Ko, Sm 4.7 (0.7) 2.5 (0.6) 3.4 (0.8)
S22 26 (M) 26 Bec Hi, Pa, Sa, Ko, Sm 4.5 (0.9) 2.3 (0.6) 3.4 (0.7)
S24 27 (M) 28 Bec Hi, Pa, Sa, Ko, Sm 3.9 (0.4) 2.2 (0.4) 3.3 (0.9)
S6 23 (M) 30 Mom Hi, Pa, Sa, Ko, Sm 3.7 (0.8) 2.9 (0.1) 2.9 (0.3)
S7 22 (M) 27 Mom Hi, Ko, Sm, Sp 2.5 (0.2) 2.3 (0.6) 2.6 (0.2)
S17 26 (F) 31 Mom Hi, Ko, Sm 2.5 (0.1) 2.8 (0.2) 2.5 (0.2)
S19 26 (F) 30 Mom Hi, Pa, Sa, Ko, Sm 2.5 (0.5) 2.7 (0.5) 2.2 (0.6)
S23 25 (F) 31 Mom Hi, Ko, Sm 2.4 (0.6) 2.1 (0.5) 2.0 (0.9)
S11 26 (M) 30 Bec Pa, Sa, Ko, Sm N/A N/A N/A
S20 27 (F) 30 Bec Pa, Sa, Ko, Sm N/A 3.1 (0.5) N/A
S21 26 (F) 29 Mom Pa, Sa, Ko, Sm 2.0 (0.4) N/A N/A
S4 26 (M) 30 N/A Pa, Sa, MRSA, Ko, Sm N/A N/A N/A
aCurrent steroid treatment, Bec (beclomethasone) or Mom (mometasone).
bAbbreviations of microbes identified by culture-based methods: Hi (H. influenzae), Pa (Pseudomonas aeruginosa), Sa (Staphylococcus aureus), Ko (Klebsiella
oxytoca), Sm (Stenotrophomonas maltophilia), MRSA (methicillin-resistant S. aureus), Sp (Streptococcus pneumoniae) and Mc (Moraxella catarrhalis).
cFold change relative to 16S RNA gene expression (standard deviation).
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membrane-associated anti-sigma factor, act to transduce signals
perceived outside the cell membrane into a transcriptional
response. On the basis of their putative action in the perception of
extracellular signals, subsequent work focused on the potential
role of the RpoE (HI0628) in the response of H. influenzae to
glucocorticosteroids.
RpoE regulates the expression of a subset of the genes
influenced by glucocorticosteroids
Previous studies demonstrated that rpoE (HI0628) is part of an
extracytoplasmic stress operon that is required for intracellular
survival of H. influenzae (Craig et al, 2001, 2002). HI0629 (mclA),
which is immediately downstream of HI0628, encodes an anti-sigma
factor that modulates the action of RpoE. To examine the extent of
the overlap between those genes regulated by glucocorticosteroids
and those regulated by rpoE or mclA, we first established the effect
of deletion of rpoE or mclA on the global gene expression patterns.
The transcriptomes of rpoE and mclA deletion mutants (constructed
as described in Materials and Methods) were compared with the
wild-type H. influenzae using RNA-seq.
Comparative transcriptome profiling of the rpoE deletion mutant
and the wild-type parent established that expression of 68 genes
was significantly influenced (> 3-fold change) by the loss of the
sigma factor (Fig 3A, Supplementary Table S2). This analysis
revealed that HI0628 controls expression of genes associated with
a range of biological functions that include bacterial motility
and attachment, stress tolerance, virulence, regulation, transport,
multidrug resistance, detoxification and signal transduction. Genes
associated with virulence and the formation of biofilms that are
regulated by HI0628 include yfe operon (HI0359–HI0362), argR
(HI1209) and potD (HI1344).
Inactivation of mclA led to significant alteration in the expression
of 40 genes, the majority encoding hypothetical proteins. MclA and
RpoE influenced expression of many of the same genes. For the
majority of these genes, regulation was in opposite direction, which
is consistent with the notion that MclA is a negative regulator of
RpoE activity (Fig 3B). Nevertheless, RpoE and MclA regulated a
small number of genes in the same direction (Fig 3B). The alteration
in expression as revealed by the RNA-seq analysis was confirmed
for selected genes by qRT–PCR (Fig 3B).
Comparisons of the effect on the transcriptome profile of rpoE
(HI0628) mutation and the addition of exogenous corticosteroid
revealed a number of genes (n = 66) whose expression appeared to
be co-regulated (Fig 3A, Supplementary Table S2). Several tran-
scriptional changes in co-regulated genes caused by rpoE mutation
and corticosteroid addition to H. influenzae were confirmed by
qRT–PCR (Fig 3C). As outlined above, MclA influenced many of
these genes in the opposite directions to RpoE. Taken together,
these findings are consistent with the contention that the RpoE–
MclA system is modulated by glucocorticosteroids leading to altered
expression of a specific subset of genes; however, our data also
indicate that a subset of genes modulated by glucocorticosteroid
addition are impacted independently of RpoE.
Glucocorticosteroids can influence biofilm formation and
antibiotic tolerance by H. influenzae in vitro
The influence of glucocorticosteroids on expression of genes impli-
cated in biofilm formation and antibiotic tolerance in H. influenzae
prompted us to examine the effect of beclomethasone on these
phenotypes. For these experiments, H. influenzae was grown in l-well
chambers with sBHI medium and the bacteria were visualized
with SYTO9 (see Materials and Methods). When grown alone,
H. influenzae formed flat biofilms with little heterogeneity (Fig 4A
(i)). The addition of 1 lM glucocorticosteroid to the sBHI medium
promoted the development of a biofilm with a similar biomass to
the bacteria grown without addition, although the structure showed
less dense packing of cells (Fig 4A(ii)). This alteration in biofilm
formation was not seen when dehydroepiandrosterone, a non-corti-
costeroid, was used in the assay (Supplementary Fig S5).
Previous studies have shown that H. influenzae biofilms cultured
in sBHI medium are extremely tolerant to antibiotic treatment,
mimicking to an extent what is seen during infection (Swords et al,
2004; Starner et al, 2008). To examine the influence of beclometha-
sone on antibiotic tolerance, H. influenzae biofilms generated in the
presence and absence of 1 lM beclomethasone for 24 h were treated
with azithromycin, an antibiotic often prescribed to asthma patients,
at 150 lg/ml, which is a concentration measured in the lungs of
patients (Starner et al, 2008). After 24 h of growth, the presence of
azithromycin had substantially inhibited biofilm formation, with
significantly decreased biofilm biomass and maximal thickness
compared to the untreated control (Fig 4A(iii) and B). The presence
of 1 lM beclomethasone decreased the effect of azithromycin on
H. influenzae biofilms, as indicated by a lesser effect on biofilm
biomass (Fig 4A(iv) and B). In contrast, the addition of dehydroepi-
androsterone, which is not a glucocorticoid, did not alter the effect
of azithromycin on H. influenzae biofilms (Supplementary Fig S5).
These data suggest that glucocorticoid treatment of H. influenzae
biofilms results in an increase in the tolerance to azithromycin.
Importantly, H. influenzae strains grown planktonically in the
presence and absence of beclomethasone showed no difference in
tolerance to azithromycin (Supplementary Fig S6).
Table 2. Location of transposon insertions that influence activation
of the H. influenzae HI1677::lux reporter by beclomethasone.
Disrupted
genea
Polar
effect
possibleb
Hits of
individual
transposon
mutantsc Gene product
HI0334 Y 2 GTP pyrophosphokinase,
RelA
HI0628 Y 1 RNA polymerase sigma
factor, RpoE
HI0910 N 1 Mutator protein, MutT
HI0999 Y 2 Ribonuclease P, RnpA
HI1275 Y 1 Tellurite resistance
protein, TehB
HI1501 N 1 Hypothetical protein
HI1605 Y 1 Hypothetical protein
aNone of these gene disruptions affect bacterial growth in complex media
and minimal media.
bPossibility of Tn5 insertion affecting expression of other (downstream) genes.
Y: yes; N: no.
cNumber of different Tn5 insertion mutations mapped to the same gene.
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The role of RpoE and MclA on H. influenzae biofilm formation
and antibiotic tolerance was also investigated by the examination of
biofilm grown in l-well chambers with sBHI medium. The rpoE and
mclA mutant showed development of a biofilm with a similar
biomass to the wild-type, although the bacteria within the structure
were slightly less densely packed (Fig 5A(i–iii)). Interestingly, muta-
tion of rpoE led to the H. influenzae biofilm being more tolerant to
azithromycin treatment compared to wild-type (Fig 5A(iv-v) and B,
Supplementary Fig S7). Similarly, mutation of mclA mutant led to
an increase in azithromycin tolerance (Fig 5B, Supplementary Fig
S7). Complementation restored these phenotypes toward wild-type
(Supplementary Fig S7). To determine whether rpoE has a similar
influence in clinical isolates of H. influenzae, the gene was
disrupted in two clinical isolates and mutants were assessed for
alterations in phenotype. In these two strains, mutation of rpoE led
to an enhanced azithromycin tolerance (Supplementary Fig S8),
indicating a similar role for RpoE in both clinical and laboratory
strains.
Glucocorticosteroids reduce the efficacy of azithromycin
treatment against H. influenzae colonization in the
mouse airway
There have been only a handful of reports addressing the
effectiveness of antibiotic treatment against H. influenzae during
respiratory infection (Vallee et al, 1992; Sekiya et al, 2008).
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Therefore, to build on our observations that beclomethasone
increases the capacity of H. influenzae to tolerate azithromycin in
an in vitro model, we wished to assess the effect of beclometha-
sone on the efficacy of azithromycin treatment in a mouse model
of infection.
Using a slight modification of the mouse model described
above (see Materials and Methods), the C57BL/6 mice were
infected with 1 × 108 CFU of H. influenzae and treated by inhaling
PBS with or without 50 lM beclomethasone. Azithromycin was
administered at a concentration of 100 mg/kg/24 h, a dose reported
by several studies (Azoulay-Dupuis et al, 1991; Girard et al, 2005).
The lung and spleen bacterial load was determined 3 days post-
infection. C57BL/6 mice infected with H. influenzae with PBS
exhibited considerable colonization (Fig 6A and B). Azithromycin
appeared to be very effective in eradicating H. influenzae from
mice treated with PBS alone (Fig 6A and B). However, with the
addition of beclomethasone, bacteria appear to be present even
after the mice had received 3 days of azithromycin treatment
(Fig 6A and B).
The role of RpoE in modulation of the efficacy of azithromycin
treatment during airway infection of mice was also investigated by
studies of the clearance of the rpoE mutant. The rpoE mutant
showed similar persistence during azithromycin treatment as the
wild-type H. influenzae with added beclomethasone (Fig 6A and B).
Addition of beclomethasone to the rpoE mutant had no additional
effect in C57BL/6 mice. These results suggest that the presence of
beclomethasone increases the capacity of H. influenzae to persist in
wild-type mice undergoing azithromycin treatment and that this
persistence effect is modulated by RpoE.
Discussion
The work in this paper suggests that glucocorticosteroids such as
beclomethasone have a direct and specific effect on H. influenzae,
influencing expression of a subset of genes that underpin alterations
in phenotypes, which include biofilm architecture and tolerance to
antibiotic treatment in vitro. In a mouse model, beclomethasone
increased the persistence of H. influenzae and reduced the efficacy
of azithromycin in clearing the infection. These latter findings are
consistent with previous observations using an infant mouse model
of bacterial meningitis, where dexamethasone was shown to
enhance the persistence of H. influenzae in blood and cerebral
spinal fluid from mice undergoing treatment with the oral antibiotic
cefuroxime (Rodriguez et al, 1991). The effects of glucocorticoster-
oid on the behavior of H. influenzae in mice may also be mediated
by influences on the host as well as by direct effects on the bacte-
rium. Indeed, it is now appreciated that the action of glucocorticoids
can be more complex than simply acting as anti-inflammatory
agents (reviewed in Cruz-Topete & Cidlowski, 2015). For example,
glucocorticoids synergistically enhance the expression of TLR2 by
H. influenzae in cultured human epithelial cells (Shuto et al, 2002).
Extrapolations from these models of infection to the asthma
airway should be made cautiously; nevertheless, several lines of
evidence support the notion that beclomethasone affects the behav-
ior of H. influenzae in the asthma airway. Analysis of sputum taken
from patients with asthma demonstrated elevated transcript level of
three glucocorticosteroid-responsive genes (HI0359, HI0628 and
HI0994), which was strongly correlated with the use of beclometha-
sone in patients colonized by H. influenzae (Table 1). In contrast,
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Figure 4. Addition of corticosteroids affects biofilm formation and antibiotic tolerance of H. influenzae.
H. influenzae biofilms were developed after 24 h in l-well chambers in sBHI mediumwith and without corticosteroid and were then treated with the antibiotic azithromycin
as specified.
A (i) H. influenzae wild-type with DMSO (solvent control); (ii) H. influenzae wild-type treated with 1 lM beclomethasone (BEC); (iii) H. influenzae wild-type treated with
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H. influenzae was visualized with SYTO9 (green strain), as described in Materials and Methods. Scale bars = 20 lm. Images shown are representative of 12 images
from five independent experiments.
B The biofilm biomass after treatments was quantified using COMSTAT. Data are presented as the average of five replicates, with error bar representing the standard
deviation of the data. Statistical significance by two-tailed Student’s t-test is indicated: **P < 0.01.
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the transcript level of these target genes was lower in patients who
were currently using mometasone (Table 1). Furthermore, testing of
a panel of H. influenzae clinical isolates showed that each had a
similar response to beclomethasone as the model strain in altered
transcription of HI0359, HI0628 and HI0994 (Supplementary Table
S3). These findings indicate that these clinical isolates do not have
an intrinsically higher level of expression of these target genes and
support the conclusion that the pattern of gene expression of bacte-
ria in sputum is, at least in part, a response to beclomethasone.
These similarities to the behavior of the model strain further suggest
that the presence of beclomethasone makes a contribution to the
enhanced ability of H. influenzae to persist during antibiotic treat-
ment for asthma.
Glucocorticosteroid treatments of asthma patients are associated
with anti-inflammatory properties, but this contrasts with the
response observed in our mouse model following bacterial infection.
In challenged mice, glucocorticosteroid treatment showed similar
increase in neutrophils and other immune cells comparable to mice
that did not receive treatment. The anti-inflammatory activities of
glucocorticosteroids in this situation may be counterbalanced
in vivo by enhanced bacterial persistence. Furthermore, as
mentioned above, glucocorticoids can have actions other than as
anti-inflammatory agents, for example, in synergistic enhancement
of the expression of TLR2 by H. influenzae (Shuto et al, 2002).
The detailed mechanisms by which beclomethasone exerts its
influence on H. influenzae gene expression and phenotypes such as
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Figure 5. Mutation of genes encoding RpoE (HI0628) and MclA (HI0629) has similar effects on biofilm formation and antibiotic tolerance in H. influenzae.
Biofilms of different H. influenzae strains were developed after 24 h in l-well chambers in sBHI medium and were then treated with the antibiotic azithromycin as specified.
A (i) H. influenzae wild-type; (ii) rpoE (HI0628); (iii) mclA (HI0629); (iv) H. influenzae wild-type treated with 150 lg/ml azithromycin; (v) rpoE (HI0628) treated with
150 lg/ml azithromycin; (vi) mclA (HI0629) treated with 150 lg/ml azithromycin. For these experiments, H. influenzae was visualized with SYTO9 (green strain), as
described in Materials and Methods. Scale bars = 20 lm. Images shown are representative of 12 images from five independent experiments.
B The biofilm biomass after treatments was quantified using COMSTAT. Data are presented as the average of five replicates, with error bars representing the standard
deviation of the data. Statistical significance by two-tailed Student’s t-test is indicated: **P < 0.01.
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biofilm formation and antibiotic tolerance remain obscure.
Currently, no glucocorticosteroid receptors have been identified in
bacterial cells. Our mutant screen coupled with comparative trans-
criptomics indicates that some of the effects of beclomethasone may
be exerted through an influence on the regulation of the ECF sigma
factor RpoE and its anti-sigma factor MclA. In the H. influenzae
genome, rpoE is organized in an operon with mclA (also known as
rseA) and rseB (HI0630). Homologous genes are present and orga-
nized in the same manner in the E. coli genome. In E. coli, RpoE is
normally sequestered to the cytoplasmic face of the inner membrane
by an anti-sigma factor, RseA, which interacts with the periplasmic
protein, RseB. Under certain stress conditions, lipopolysaccharides
(LPS) and outer membrane proteins (OMPs) are not incorporated
into the outer membrane and accumulate in the periplasm. Periplas-
mic LPS binds RseB, freeing RseA to be cleaved by the OMP-
activated protease DegS. This initiates further RseA degradation by
the protease RseP, resulting in the release of RpoE into the cytosol
(Barchinger & Ades, 2013; Lima et al, 2013). Over-expression of
RseB down-regulates the RpoE pathway. In addition to this post-
translational regulation, transcription of the rpoE gene is positively
auto-regulated. It is highly likely that H. influenzae possesses a simi-
lar mechanism for the regulation of RpoE as in E. coli, although rpoE
is essential in E. coli but not in H. influenzae. The overlapping
effects on the transcriptome and phenotypes of the addition of
beclomethasone, mutation of the sigma factor (rpoE) and mutation
of the anti-sigma factor (mclA) genes are not consistent with a model
in which glucocorticosteroids activate the RpoE stress response, but
suggest they act to suppress the action of RpoE. Consistent with this
contention, beclomethasone had no effect on the profile of outer
membrane proteins of wild-type H. influenzae (Supplementary
Fig S9). Suppression of RpoE action could involve direct binding of
glucocorticosteroids to the sigma factor. To address this possibility,
we determined the ability of purified RpoE to bind beclomethasone
by isothermal titration calorimetry (Supplementary Fig S10). The
experimental data show no binding and therefore do not support a
direct binding model. These experiments do not rule out other mech-
anisms of beclomethasone action that include an inhibition of the
regulated proteolysis of MclA/RseA or an influence on the RpoE::
MclA balance by differential influences on transcription.
Our data show that the H. influenzae rpoE mutant biofilms were
more tolerant of antimicrobial treatment than the wild-type. In
contrast, rpoE mutants of other Gram-negative bacteria such as
Salmonella enterica serovar Typhimurium and Vibrio cholerae have
reduced survival in the presence of antimicrobials and attenuated
virulence in various in vitro models (Humphreys et al, 1999;
Osborne & Coombes, 2009). Furthermore, the H. influenzae mclA
mutant biofilms showed similar tolerance to antibiotic treatment
than the wild-type. These findings support the emerging view that
biofilm formation in most bacteria instigates a completely different
range of regulatory events to govern antimicrobial susceptibility
than those activated during planktonic growth (Anderson et al,
2008; Osborne & Coombes, 2009).
Although the anti-inflammatory clinical benefits of glucocortico-
steroid treatment are undeniable in many respiratory diseases,
several recent studies have implicated such therapies in the develop-
ment of bacterial pneumonia in asthma and COPD (Singanayagam
et al, 2010). In addition, chronic bacterial infections of neutrophilic
asthma airways that involve H. influenzae are connected to the
development of airway disease that is steroid resistant (Essilfie et al,
2012). Our studies point to the need to consider the impact on bacte-
rial behavior as one factor in the choice of which glucocorticosteroid
to be used and in design of the treatment regime. For example,
prednisolone triggered similar alterations in gene expression of
H. influenzae to those seen with beclomethasone, whereas mometa-
sone had little effect (Supplementary Fig S4). Would the use of
mometasone therefore be preferential to other glucocorticosteroids
for patients also being treated with azithromycin? Would stopping
the glucocorticosteroid treatment before antibiotics are applied
promote the antibacterial effect? While several clinical trials have
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Figure 6. Corticosteroid treatment affects H. influenzae clearance by
antibiotic treatment in the mouse airway.
A, B Mice infected intranasally with 1 × 108 CFU H. influenzae and treated by
inhaling PBS with or without 50 lM beclomethasone. Azithromycin was
administered at a concentration of 100 mg/kg/24 h, daily for 3 days after
infection. On day 3–4 after infection, the mice were harvested, and
bacterial loads were determined in lung (A) and spleen (B) homogenates.
Values represent the mean  standard deviation (SD). The data are
pooled from three independent experiments. Statistical significance by
two-tailed Student’s t-test is indicated: *P < 0.05, **P < 0.01.
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reported an increased risk of bacterial pneumonia with the use of
glucocorticosteroids in asthma and COPD patients, only specific
patient trials designed to assess the above questions will inform
clinicians. Overall, our data suggest the requirement for further
studies to examine the action of glucocorticosteroids on bacteria that
colonize the airway of individuals who rely on these therapeutic
agents.
Materials and Methods
Bacterial strains, growth conditions and media
Strains and plasmids used in this study are described in Supplemen-
tary Table S4. H. influenzae strains were grown (overnight at 37°C)
on brain–heart infusion agar plates supplemented with 10 lg/ml of
hemin and 10 lg/ml of NAD (referred to as sBHI). Escherichia coli
was grown on Luria-Bertani (LB) broth or LB agar plates at 37°C.
When appropriate, the following concentrations of antibiotics were
used: 50 lg/ml of kanamycin (Kan), 100 lg/ml of erythromycin
(Em) and 150 lg/ml of azithromycin. Antibiotics were purchased
from Sigma-Aldrich.
DNA manipulations
Molecular biological methods such as isolation of plasmid and chro-
mosomal DNA, PCR, plasmid transformation as well as restriction
digestion were carried out using standard protocols (Sambrook
et al, 1989). PCR products were cleaned using the PCR purification
kit (QiagenTM), and DNA fragments were recovered from agarose
gels using QIAquick minielute gel purification kit (QiagenTM). Oligo-
nucleotide primers were purchased from Sigma-GenosysTM.
Construction of mutants in H. influenzae strains
Mutants in H. influenzae strains were constructed using a modified
protocol of the one described previously (Morey et al, 2013). Genes
HI0628 and HI0629 were amplified separately in two parts by PCR
with Taq polymerase (PromegaTM) using Rd KW20 genomic DNA as
the template. Primers were designed based on the genome
sequence of H. influenzae Rd KW20 and detailed in Supplementary
Table S5. The first part of each gene was amplified to include
~200 bp of the region upstream of the predicted open reading
frame, while the second part of the gene included ~200 bp down-
stream of the predicted stop codon. As restriction sites external to
these flanking regions, internal SmaI sites were incorporated onto
each amplicon. The two separately amplified sequences were re-
assembled in pBluescript and cloned into E. coli DH5a. Restriction
digest using SmaI allowed the integration of an erythromycin
cassette, which was taken from pBSLErm (Allen et al, 2005). The
construct was linearized and used to transform chemically compe-
tent Rd KW20 using standard protocols. Transformants, which
had successfully undergone recombination, were selected on
sBHI containing 10 lg/ml Em. Complementation of mutant
H. influenzae strains was carried out by inserting the relevant gene
into open reading frame (ORF) HI0601.1; this ORF contains a
frameshift in H. influenzae Rd KW20. The approach has been
deployed successfully in a previous study (Morey et al, 2013).
Copies of HI0628 and HI0629 genes were used to complement
respective mutants (Supplementary Table S4).
Construction of chromosomal reporter fusions
The protocol used for the construction of the lux reporter fusion for
HI1677 was a modification of the RED recombination protocols
previously described by Lesic and Rahme (2008) and McCarthy et al
(2010). The HI1677 gene was amplified by PCR using forward and
reverse primers HI1677-F and HI1677-R to include the region 250 bp
upstream of the gene and was cloned into pGLuc. The HI1677::lux
fusion was removed by restriction digest using HindIII and XbaI and
cloned into pME6032-RedS cut with the same enzymes. This
construct was electroporated into H. influenzae wild-type. Trans-
conjugants were grown in sBHI to an optical density at 600 nm of
0.4 at 37°C, and recombination was induced by the addition of
0.2% L-arabinose for 1.5 h. The correct integration of the reporter
cassette was confirmed by colony PCR using a reverse primer
specific to the reporter and a forward primer specific to the
upstream region of the target gene.
Transposon mutagenesis and screening
A library of mutants in the H. influenzae strain carrying the
HI1677::lux fusion was constructed using EZ::Tn<KAN-2> Tnp
transposome (Epicentre technologies) as directed by the manufac-
turer. Briefly, 100 ng of transposon-containing plasmid was electro-
porated into newly prepared electrocompetent H. influenzae cells.
Strains carrying the transposon insertion were identified by selec-
tion on Kan. The library of mutants was screened for loss of respon-
siveness of HI1677::lux expression to exogenous beclomethasone
(50 lM). Strains were inoculated into microtiter wells containing
sBHI medium with 50 lM beclomethasone by using a Qpix robot
(GenetixTM). The luciferase activity lysates of bacteria from each well
were quantified as described previously (Deiwick et al, 1999).
Briefly, equal amounts of bacterial cells as adjusted by the determi-
nation of optical density at 600 nm (OD600) were harvested by
centrifugation and lysed. Luciferase activity in bacterial cell lysates
was assayed using Luciferase Assay Kit (PromegaTM) and quantified
in black microtiter plates by a Wallac Victor 21420 Multilabel
Counter plate reader (Perkin ElmerTM).
Identification of transposon insertion sites
Genomic DNA was extracted from transposon mutants of interest as
previously described (Sambrook et al, 1989). To identify the genes
that were interrupted by the EZ::Tn transposon, the random amplifi-
cation of transposon ends (RATE) PCR method of Ducey and collea-
gues (Ducey et al, 2005) was utilized. Amplicons were sequenced
using the Inv-specific primers (Supplementary Table S5). Sequence
data generated were examined with blastn and blastx (http://
www.ncbi.nlm.nih.gov/BLAST/) software.
Enrollment of subjects and sputum sample collection
Sputum samples from 24 asthma patients (January 2012–September
2013) were collected from Cork University Hospital. All study partic-
ipants provided written consent. The Clinical Research Ethics
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Committee of the Cork Teaching Hospitals (CREC) granted full
approval to the project. All sputa were analyzed and then frozen at
80°C in 1-ml aliquots for further study. Patient clinical parameters
were also recorded including the participant’s age, lung function,
pulmonary administered steroids or antibiotics, and colonization by
microorganisms identified by standard clinical laboratory cultivation
techniques.
Ethics statement
Animal experiments were conducted in compliance with a proto-
col (# 16-051-11) approved by The Animal Experimentation
Ethics Committee (AEEC) of University College Cork or Cork
University Hospital. The Minister for Health accredits the Univer-
sity College Cork for conducting animal experiments. AEEC is
guided by legislative requirements, in particular the Cruelty to
Animals Act as amended and supplemented by the European
Communities.
Infection and treatment of animals
Mouse infection was performed with modification of the proce-
dures described by Sekiya et al (2008) and Wu et al (1997).
Four-week-old female C57BL/6 mice (Charles River) were injected
intraperitoneally with cyclophosphamide at 3 days pre-infection
and on the day of infection at a dose of 66 lg/g of body weight.
Sample size was always five unless otherwise stated. Bacterial
strains used for the intranasal challenge were grown in sBHI broth
to an optical density (600 nM) of approximately 0.25. Subse-
quently, 20 ll of culture to have a final inoculum of 1 × 109
colony-forming unit (CFU) was administered to each mouse. After
every 24-h period, animals were treated with 100 ll of PBS or PBS
containing beclomethasone (50 lM) was pipetted into the nares
and involuntarily inhaled. Five mice were sacrificed by carbon
dioxide asphyxiation at days 1, 3, 5 and 7 post-challenge. Bronc-
hoalveolar lavage (BAL) fluid (100 ll) and blood (75 ll) were
collected from each mouse. After exposure of the trachea, the
nasopharynx was washed with 1 ml of buffer (0.5% trypsin,
0.02% EDTA in sterile PBS) by insertion of a 26-gauge needle
sheathed in tubing into the tracheal end of the upper respiratory
tract. Buffer was allowed to drip into the nasopharynx slowly and
was collected from the nose, with each wash taking approximately
40 s. Both lungs and spleen were entirely removed, rinsed twice in
PBS to remove excess blood, weighed and placed in 2 ml of sterile
PBS. The lungs and spleen were then homogenized at 10,000 g for
approximately 10 s. All blood, lung, spleen and BAL washout
samples were then serially diluted and plated on agar to determine
the number of viable bacteria. Total cells present in the BAL were
counted, and a differential cell count was performed on cytospins
stained with Diff Quick.
For animal experiments examining the effectiveness of azithro-
mycin treatment against H. influenzae during respiratory infection,
mice were intranasally inoculated with 20 ll of the bacterial
suspension in PBS (1 × 108 CFU/mouse). Each mouse was admin-
istered azithromycin once daily over the course of infection. On
day 3 after infection, the lung and spleen were removed, homo-
genized with PBS and plated on agar to determine the number of
viable bacteria.
RNA extraction
H. influenzae Rd KW20 strains (including mutants) were inoculated
at an OD600 of 0.1 in sBHI [with 50 lM beclomethasone dipropio-
nate (Sigma-Aldrich) if used]. Cultures were harvested during mid-
log phase (OD600 = 0.7), and RNA was extracted using the High Pure
RNA Isolation Kit (Roche). For the in vivo RNA samples, infected
animals as described above were euthanized < 72 h post-infection.
RNA was isolated from airway homogenate pellets using TRIzol
according to the manufacturer’s instructions. Samples were treated
with DNase, and then rRNA was removed from 1 to 5 lg of total
RNA using the Ribo-Zero kit for Gram-negative bacteria (Epicentre).
rRNA-depleted samples were concentrated by EtOH precipitation.
Gene expression profiling experiments
RNA quality was assessed on a Bioanalyser PicoChip (Agilent), and
RNA quantity was measured using the RNA assay on QuBit fluoro-
meter (Life Technologies). Ribosomal RNA was depleted with Ribo-
ZeroTM rRNA Removal Kits for Gram-negative bacteria (Epicentre).
The percentage of rRNA contamination was checked on a Bioanaly-
ser PicoChip (Agilent).
The rRNA-depleted sample was processed using the Illumina
TruSeq RNA v2 sample preparation kit. In brief, the sample was
chemically fragmented to ~200 nt in length and the cleaved RNA
fragments were primed with random hexamers into first-strand
cDNA using reverse-transcriptase and random primers. The RNA
template was removed, and a replacement strand was synthesized
to generate ds cDNA. The ds cDNA was end-repaired to remove the
overhangs from the fragmentation into blunt ends. A single “A”
nucleotide was added to the 30 ends on the blunt fragments, which
is complementary to a “T” nucleotide on the 30 end of the Illumina
adapters. At this stage, adapters containing 6-nt barcodes were used
for different samples to allow the pooling of multiple samples
together. The resulted bar-coded samples were enriched by 10
cycles of PCR to amplify the amount of DNA in the library. The final
cDNA libraries were sequenced on an Illumina HiSeq2000 as per the
manufacturer’s instructions.
The fluorescent images were processed to sequences using the
Pipeline Analysis software 1.8 (Illumina). Raw sequence data
obtained in Illumina FASTQ-format were first separated by their
barcode sequence by comparing the first six bases with the expected
barcode sequences. Successfully detected barcodes were removed
from the sequence leaving paired-end reads of 30 nt in length, while
reads containing no recognizable barcode sequence were discarded.
Reads for each sample were aligned to the H. influenzae Rd
KW20 GCA_000027305.1 genome assembly (Ensembl bacteria
genome database) using Bowtie version 2.0 with default parameters
and randomness which when the program is faced with a sequence
that aligns to multiple parts of the genome equally well, chooses
one region randomly and the others are discarded. Transcript abun-
dance was determined using the feature counts program to estimate
the level of transcription for each gene, and the number of reads
that mapped within each annotated coding sequence (CDS) was
determined.
Differential expression was assessed using DESeq2, which esti-
mates variance-mean dependence in read counts and uses negative
binomial distribution to test for differential expression. The P-value
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for fold change is calculated and adjusted to remove the effects of
repetition. The entire dataset has been deposited in the European
Bioinformatics Institute (EBI) European Nucleotide Archive site
under accession number ERG003569.
Quantitative real-time PCR assays
The effect of HI0628 or HI0629 mutation or the addition of 50 lM
of various steroids [beclomethasone dipropionate, prednisone,
mometasone, dehydroepiandrosterone (Sigma-Aldrich)] to H. influenzae
strains (including clinical isolates) on expression of genes was
monitored by qRT–PCR. RNA was isolated from cultures of wild-
type strain, wild-type supplemented with 50 lM steroid or mutant
grown to an OD600 of 0.7, converted to cDNA using AMV Reverse
Transcriptase (Promega) using conditions specified by the manufac-
turer. The quantitative PCR was carried out using Platinum SYBR
Green qPCR SuperMix-UDG (Invitrogen). The primers used to
amplify the genes are listed in Supplementary Table S2. As a
control, RT–PCR was similarly applied to analyze expression of the
16S rRNA gene. The reverse transcription and PCR protocols were
performed as described previously. The amplified products were
subjected to electrophoresis on 2.5% agarose gels and stained with
ethidium bromide. RT–PCR analysis was repeated at least twice for
each gene tested.
Cultivation and image analysis of biofilms
H. influenzae strains were allowed to form biofilm in static l-well
chambers (Ibidi-iTreat) containing sBHI media incubated at 37°C
as previously described (Jurcisek et al, 2011). These chambers
have a physically treated cycloolefin polymer exterior with a
surface energy of around 72 mN/m. When required, steroid at a
concentration of 1 or 10 or 50 lM was added during initial biofilm
formation. Biofilm antibiotic susceptibility testing was carried out
on 24-h-old biofilms of H. influenzae strains grown as described
above (in the presence or absence of steroid as required) and then
treated with 150 lg/ml azithromycin for 3 h before visualization
and quantification.
Biofilms were stained and visualized using SYTO 9 to color live
biofilm cells green and propidium iodide stain (Life Tech), a
normally cell-impermeable stain, to color dead cells red. All micro-
scopic observations and image acquisitions were performed on a
Zeiss LSM780 confocal laser scanning microscope equipped with an
argon–krypton laser and with detectors and filter sets for monitoring
SYTO 9 and for the recording of reflection (light) images. Images
were obtained using a 63×/1.4 Plan-APOChromat differential inter-
ference contrast objective or a 40×/1.3 Plan-Neofluor oil objective.
Multichannel simulated fluorescence projection (SFP) images, verti-
cal xz sections through the biofilms and simulated three-
dimensional (3D) images were generated using the IMARIS software
package (Bitplane). Biofilm images were obtained to quantify
biomass as described previously using COMSTAT software.
Statistical analysis
Significant differences between the means plus or minus standard
deviations (SDs) of different groups were examined using a two-
tailed unpaired Student’s t-test. A P-value of less than 0.05 was
regarded as statistically significant. All variables remained signifi-
cant after multiple testing.
Supplementary information for this article is available online:
http://embomolmed.embopress.org
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The paper explained
Problem
Glucocorticosteroids are used as a main treatment to reduce airway
inflammation in the majority of asthma patients. However, a large
proportion of asthmatic patients that receive prolonged corticosteroid
treatment develop chronic Haemophilus influenzae infection along
with reduced responsiveness to steroid therapy. One aspect of the
pathogenesis and therapy of asthma that has not received consider-
ation is the potential direct influence of glucocorticosteroids on the
behavior of H. influenzae. In particular, whether glucocorticosteroids
have a direct impact on bacterial functions that promote persistence
and tolerance to antibiotics remains an open question that we
address in this paper.
Results
We have examined the impact of glucocorticosteroid treatment on
H. influenzae during respiratory infection and neutrophilic asthma, as
well as investigating impacts on H. influenzae biology in vitro. We
show that the presence of beclomethasone promotes H. influenzae
persistence without influencing the host inflammatory response in a
mouse model of acute infection. Comparative transcriptional analysis
of H. influenzae grown under standard laboratory conditions in the
absence and presence of beclomethasone revealed that this glucocorti-
costeroid induces altered expression of genes implicated in biofilm
formation, host colonization and survival in vivo. Importantly, exami-
nation of sputum samples from asthma patients undertaking inhaled
steroid treatment showed that many of the H. influenzae genes with
expression that was responsive to corticosteroid in vitro also had
altered expression in bacteria during infection. Clinical isolates of
H. influenzae showed similar alteration in the expression of specific
target genes in response to beclomethasone or prednisone in vitro. A
mutant screen and transcriptome profiling identified RpoE (HI0628) as
an element in the corticosteroid response that acts to regulate a
subset of the genes influenced by glucocorticosteroids. Mutation of
rpoE or addition of corticosteroid to H. influenzae led to alteration in
biofilm formation and enhanced resistance to azithromycin, an antibi-
otic often prescribed to asthma patients. Furthermore, in an animal
model of respiratory infection, the presence of corticosteroid or muta-
tion of rpoE promoted azithromycin resistance.
Impact
These results reveal a previously unrecognized contribution of gluco-
corticosteroid treatment to bacterial airway infections particularly in
the context of asthma. Specifically, the findings suggest that gluco-
corticosteroid treatment influences H. influenzae behavior in the
airway affecting biofilm formation, persistence and the efficacy of
antibiotic therapy. These observations may inform clinical practice in
the use of glucocorticosteroids in the treatment of asthma. In particu-
lar, the work points toward the need to consider the impact on bacte-
rial behavior as one factor in the choice of which steroid to be used
and in design of the treatment regime in the context of respiratory
disease.
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